[HTML][HTML] Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PLoS …, 2021 - journals.plos.org
Rationale Murine syngeneic tumor models have revealed efficacious systemic antitumor
responses following primary tumor in situ vaccination combined with targeted radionuclide …
responses following primary tumor in situ vaccination combined with targeted radionuclide …
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Rationale Murine syngeneic tumor models have revealed efficacious systemic antitumor
responses following primary tumor in situ vaccination combined with targeted radionuclide …
responses following primary tumor in situ vaccination combined with targeted radionuclide …
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PLoS ONE, 2021 - go.gale.com
Rationale Murine syngeneic tumor models have revealed efficacious systemic antitumor
responses following primary tumor in situ vaccination combined with targeted radionuclide …
responses following primary tumor in situ vaccination combined with targeted radionuclide …
[PDF][PDF] Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PLoS …, 2021 - pdfs.semanticscholar.org
Methods The three component of the combination immuno-radiotherapy approach were
employed either separately or in combination in companion dogs with advanced stage …
employed either separately or in combination in companion dogs with advanced stage …
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PLoS …, 2021 - search.ebscohost.com
Rationale: Murine syngeneic tumor models have revealed efficacious systemic antitumor
responses following primary tumor in situ vaccination combined with targeted radionuclide …
responses following primary tumor in situ vaccination combined with targeted radionuclide …
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion …
K Magee, IR Marsh, MM Turek, J Grudzinski… - Plos one, 2021 - europepmc.org
Methods The three component of the combination immuno-radiotherapy approach were
employed either separately or in combination in companion dogs with advanced stage …
employed either separately or in combination in companion dogs with advanced stage …
[引用][C] Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PLoS …, 2021 - ui.adsabs.harvard.edu
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide
combination immuno-radiotherapy approach in a comparative (companion dog) setting …
combination immuno-radiotherapy approach in a comparative (companion dog) setting …
[HTML][HTML] Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative …
K Magee, IR Marsh, MM Turek, J Grudzinski… - PLoS ONE, 2021 - ncbi.nlm.nih.gov
Methods The three component of the combination immuno-radiotherapy approach were
employed either separately or in combination in companion dogs with advanced stage …
employed either separately or in combination in companion dogs with advanced stage …